(NASDAQ: DXCM) Dexcom's forecast annual revenue growth rate of 13.26% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.75%.
Dexcom's revenue in 2025 is $4,148,000,000.On average, 9 Wall Street analysts forecast DXCM's revenue for 2025 to be $1,806,933,704,666, with the lowest DXCM revenue forecast at $1,798,165,788,836, and the highest DXCM revenue forecast at $1,818,516,168,138. On average, 9 Wall Street analysts forecast DXCM's revenue for 2026 to be $2,084,536,404,794, with the lowest DXCM revenue forecast at $2,025,780,272,091, and the highest DXCM revenue forecast at $2,138,436,678,204.
In 2027, DXCM is forecast to generate $2,362,986,449,231 in revenue, with the lowest revenue forecast at $2,227,907,767,782 and the highest revenue forecast at $2,419,695,388,671.